10 Stocks on Jim Cramer’s Radar

3. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 70

A viewer called to ask about Bristol-Myers Squibb Company (NYSE:BMY) and if they should hold it. This is what Cramer had to say:

“No, no, you don’t hold it. You buy more. This COBENFY is this, I’m telling you, this is a radical new drug. It’s the first new drug for schizophrenia. We’ve seen it work much better than the others. No weight gain and I think it’s remarkable. 4% yield and a guy, Chris Boerner, who I think is dynamite at the helm. I’m not telling you to schnitzel, buy, sell, whatever. I like Bristol Myers.”

Bristol-Myers (NYSE:BMY) focuses on creating therapies for a range of diseases in multiple therapeutic areas.